Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 331.00M | £ 173.00M | £ 92.33M | £ 217.68M | £ 438.76M |
Total Assets | £ 3.75B | £ 3.64B | £ 3.56B | £ 3.36B | £ 3.65B |
Total Debt | £ 2.26B | £ 2.27B | £ 2.05B | £ 2.03B | £ 2.06B |
Net Debt | £ 1.93B | £ 2.09B | £ 1.96B | £ 1.81B | £ 1.63B |
Total Liabilities | £ 2.91B | £ 2.89B | £ 2.75B | £ 2.63B | £ 2.65B |
Stockholders Equity | £ 840.00M | £ 746.00M | £ 809.61M | £ 732.97M | £ 993.02M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |